Rnaimmune, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 26
Rang # Quantité totale PI 56 053
Note d'activité PI 2,4/5.0    37
Rang # Activité PI 20 371
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

9 2
2 0
13 0
0
 
Dernier brevet 2025 - Compositions and methods of ribo...
Premier brevet 2021 - Composition and method of mrna v...
Dernière marque 2023 - RNAIMMUNE
Première marque 2023 - RNAIMMUNE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines. Provide...
Invention Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines. Provided...
Invention Ras mrna cancer vaccines and compositions and methods thereof. Methods are provided for potent mR...
Invention Anti-pd-l1 antibodies and uses thereof. The present disclosure relates generally to immunoglobuli...
Invention Compositions and methods of mrna vaccines against novel coronavirus infection. Provided herein i...
2023 Invention Multiplexed tp53 and pan-ras mrna cancer vaccines. Compositions and methods are provided for pot...
Invention Compositions and methods of ribonucleic acid vaccines encoding nye-so-1. Compositions and methods...
Invention Composition and methods for mrna vaccines against novel omicron coronavirus infections. Provided...
Invention Composition and methods for mrna vaccines against novel omicron coronavirus infections. Provided ...
Invention Combination ras mrna cancer therapy. Compositions and methods are provided for potent mRNA vaccin...
Invention Lyophilized nanoparticle compositions and methods of use thereof. A method of making a nanopartic...
P/S vaccines for infectious disease, cancer, heart disease, and rare diseases; therapeutic preparatio...
Invention Compounds and compositions for drug delivery. Novel lipids, compositions, and methods of using t...
Invention Compounds and compositions for drug delivery. Novel lipids, compositions, and methods of using th...
2022 Invention Composition and methods of mrna vaccines against novel coronavirus infection.
Invention Multiplexed tp53 and pan-ras mrna cancer vaccines. Compositions and methods are provided for pote...
2021 Invention Pan-ras mrna cancer vaccines. Compositions and methods are provided for potent mRNA vaccines for...
Invention Pan-ras mrna cancer vaccines. Compositions and methods are provided for potent mRNA vaccines for ...
Invention Composition and method of mrna vaccines against novel coronavirus infection. Compositions and me...
Invention Composition and method of mrna vaccines against novel coronavirus infection. Compositions and met...